These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical Commentary. Stein CA Clin Genitourin Cancer; 2015 Oct; 13(5):407-9. PubMed ID: 26119230 [No Abstract] [Full Text] [Related]
14. Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer. Rhea LP; Gupta B; Aragon-Ching JB Asian J Androl; 2019; 21(2):107-108. PubMed ID: 30460933 [TBL] [Abstract][Full Text] [Related]
15. Leading causes of castration-resistant prostate cancer. Lu M; Lu H; Kong Q Expert Rev Anticancer Ther; 2015 Apr; 15(4):425-32. PubMed ID: 25645203 [TBL] [Abstract][Full Text] [Related]
16. Novel agents for castration-resistant prostate cancer: Early experience and beyond. Fujimoto N Int J Urol; 2016 Feb; 23(2):114-21. PubMed ID: 26311471 [TBL] [Abstract][Full Text] [Related]
17. Cabazitaxel for the therapy of metastatic castration-resistant prostate cancer in the aftermath of the CHAARTED trial. Pal SK; Sonpavde G BJU Int; 2015 Dec; 116(6):839-40. PubMed ID: 26542327 [No Abstract] [Full Text] [Related]